-
4
-
-
84858136552
-
-
Lippincott Williams & Wilkins, Philadelphia
-
Sabin T: Generalized peripheral neuropathy: symptoms, signs, and syndrome. Peripheral neuropathy: a practical approach to diagnosis and management, Lippincott Williams & Wilkins, Philadelphia, pp3-19, 2001.
-
(2001)
Generalized Peripheral Neuropathy: Symptoms, Signs, and Syndrome. Peripheral Neuropathy: A Practical Approach to Diagnosis and Management
, pp. 3-19
-
-
Sabin, T.1
-
6
-
-
0033915199
-
Managing the neurotoxicity of paclitaxel (Taxol®) and docetaxel (Taxotere®) with neurotrophic factors
-
Apfel SC: Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors. Cancer Invest 18:564-573, 2000. (Pubitemid 30485673)
-
(2000)
Cancer Investigation
, vol.18
, Issue.6
, pp. 564-573
-
-
Apfel, S.C.1
-
7
-
-
0030926947
-
Paclitaxel neurotoxicity: Clinical and neurophysiological study of 23 patients
-
DOI 10.1007/BF01999566
-
Pace A, Bove L, Aloe A, Nardi M, Pietrangeli A, Calabresi F, Innocenti P, Jandolo B: Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients. ItalJNeurol Sci 18:73-79, 1997. (Pubitemid 27238776)
-
(1997)
Italian Journal of Neurological Sciences
, vol.18
, Issue.2
, pp. 73-79
-
-
Pace, A.1
Bove, L.2
Aloe, A.3
Nardi, M.4
Pietrangeli, A.5
Calabresi, F.6
Innocenti, P.7
Jandolo, B.8
-
8
-
-
0033921499
-
Phantom limb pain as a manifestation of paclitaxel neurotoxicity
-
Khattab J, Terebelo HR, Dabas B: Phantom limb pain as a manifestation of paclitaxel neurotoxicity. Mayo Clin Proc 75:740-742, 2000. (Pubitemid 30441504)
-
(2000)
Mayo Clinic Proceedings
, vol.75
, Issue.7
, pp. 740-742
-
-
Khattab, J.1
Terebelo, H.R.2
Daras, B.3
-
9
-
-
0030037366
-
Motor neuropathy due to docetaxel and paclitaxel
-
Freilich RJ, Balmaceda C, Seidman AD, Rubin M, DeAngelis LM: Motor neuropathy due to docetaxel and paclitaxel. Neurology 47:115-118, 1996. (Pubitemid 26243870)
-
(1996)
Neurology
, vol.47
, Issue.1
, pp. 115-118
-
-
Freilich, R.J.1
Balmaceda, C.2
Seidman, A.D.3
Rubin, M.4
DeAngelis, L.M.5
-
10
-
-
0028095121
-
Paclitaxel (Taxol) induces cumulative mild neurotoxicity
-
van Gerven JM, Moll JW, van den Bent MJ, Bontenbal M, van der Burg ME, Verweij J, Vecht CJ: Paclitaxel (Taxol) induces cumulative mild neurotoxicity. EurJ Cancer 30A:1074-1077, 1994.
-
(1994)
EurJ Cancer
, vol.30 A
, pp. 1074-1077
-
-
Van Gerven, J.M.1
Moll, J.W.2
Van Den Bent, M.J.3
Bontenbal, M.4
Van Der Burg, M.E.5
Verweij, J.6
Vecht, C.J.7
-
11
-
-
0031757277
-
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer
-
Seidman AD, Hudis CA, Albanel J, Tong W, Tepler I, Currie V, Moynahan ME, Theodoulou M, Gollub M, Baselga J, Norton L: Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. J Clin Oneol 16:3353-3361, 1998. (Pubitemid 28481632)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.10
, pp. 3353-3361
-
-
Seidman, A.D.1
Hudis, C.A.2
Albanel, J.3
Tong, W.4
Tepler, I.5
Currie, V.6
Moynahan, M.E.7
Theodoulou, M.8
Gollub, M.9
Baselga, J.10
Norton, L.11
-
12
-
-
0035890811
-
Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer
-
Perez EA, Vogel CL, Irwin DH, Kirshner JJ, Patel R: Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol 19:4216-4223, 2001. (Pubitemid 33081639)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.22
, pp. 4216-4223
-
-
Perez, E.A.1
Vogel, C.L.2
Irwin, D.H.3
Kirshner, J.J.4
Patel, R.5
-
13
-
-
0037231194
-
Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer
-
Christodoulou C, Klouvas G, Pateli A, Mellou S, Sgouros J, Skarlos DV: Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer. Anticancer Res 23:737-744, 2003. (Pubitemid 36358482)
-
(2003)
Anticancer Research
, vol.23
, Issue.B1
, pp. 737-744
-
-
Christodoulou, C.1
Klouvas, G.2
Pateli, A.3
Mellou, S.4
Sgouros, J.5
Skarlos, D.V.6
-
14
-
-
0037977159
-
Weekly paclitaxel (Taxol®) with or without trastuzumab (Herceptin®) in advanced breast cancer: A community-based observation study
-
DOI 10.1159/000069832
-
von Moos R, Thurlimann B: Weekly Paclitaxel (Taxol(R)) with or without Trastuzumab (Herceptin (R)) in Advanced Breast Cancer: A Community- Based Observation Study. Onkologie 26:128-132, 2003. (Pubitemid 36677076)
-
(2003)
Onkologie
, vol.26
, Issue.2
, pp. 128-132
-
-
Von Moos, R.1
Thurlimann, B.2
-
15
-
-
7844239773
-
A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
-
DOI 10.1023/A:1008445123416
-
Gelmon KA, Tolcher A, O'Reilly S, Campbell C, Bryce C, Shenkier T, Ragaz J, Ayers D, Nakashima L, Rielly S, Dulude H: A phase I- l] study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer. Ann Oncol 9:1247-1249, 1998. (Pubitemid 28552816)
-
(1998)
Annals of Oncology
, vol.9
, Issue.11
, pp. 1247-1249
-
-
Gelmon, K.A.1
Tolcher, A.2
O'Reilly, S.3
Campbell, C.4
Bryce, C.5
Shenkier, T.6
Ragaz, J.7
Ayers, D.8
Nakashima, L.9
Rielly, S.10
Dulude, H.11
-
16
-
-
0346455296
-
Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer
-
Kuroi K, Tanaka C, Bando H, Saji S, Hayashi K, Toi M" Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer. Gan To Kagaku Ryoho 29:55-60, 2002.
-
(2002)
Gan to Kagaku Ryoho
, vol.29
, pp. 55-60
-
-
Kuroi, K.1
Tanaka, C.2
Bando, H.3
Saji, S.4
Hayashi, K.5
Toi, M.6
-
17
-
-
0035695654
-
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study
-
DOI 10.1023/A:1013184301155
-
Fountzilas G, Tsavdaridis D, Kalogera-Fountzila A, Christodoulou CH, Timotheadou E, Kalofonos CH, Kosmidis P, Adamou A, Papakostas P, Gogas H, Stathopoulos G, Razis E, Bafaloukos D, Skarlos D: Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase I study. Ann Onco112:1545-1551, 2001. (Pubitemid 34065883)
-
(2001)
Annals of Oncology
, vol.12
, Issue.11
, pp. 1545-1551
-
-
Fountzilas, G.1
Tsavdaridis, D.2
Kalogera-Fountzila, A.3
Christodoulou, Ch.4
Timotheadou, E.5
Kalofonos, Ch.6
Kosmidis, P.7
Adamou, A.8
Papakostas, P.9
Gogas, H.10
Stathopoulos, G.11
Razis, E.12
Bafaloukos, D.13
Skarlos, D.14
-
18
-
-
0035873815
-
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
-
Seidman AD, Fornier MN, Esteva FJ, Tan L, Kaptain S, Bach A, Panageas KS, Arroyo C, Valero V, Currie V, Gilewski T, Theodoulou M, Moynahan ME, Moasser M, Sklarin N, Dickler M, D'Andrea G, Cristofanilli M, Rivera E, Hortobagyi GN, Norton L, Hudis CA: Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Onco119:2587-2595, 2001. (Pubitemid 32441364)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.10
, pp. 2587-2595
-
-
Seidman, A.D.1
Fornier, M.N.2
Esteva, F.J.3
Tan, L.4
Kaptain, S.5
Bach, A.6
Panageas, K.S.7
Arroyo, C.8
Valero, V.9
Currie, V.10
Gilewski, T.11
Theodoulou, M.12
Moynahan, M.E.13
Moasser, M.14
Sklarin, N.15
Dickler, M.16
D'Andrea, G.17
Cristofanilli, M.18
Rivera, E.19
Hortobagyi, G.N.20
Norton, L.21
Hudis, C.A.22
more..
-
19
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2
-
DOI 10.1056/NEJM200103153441101
-
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N EnglJMed 344:783-792, 2001. (Pubitemid 32222155)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
Fleming, T.7
Eiermann, W.8
Wolter, J.9
Pegram, M.10
Baselga, J.11
Norton, L.12
-
20
-
-
0029051997
-
Paclitaxel-induced neuropathy
-
Postma TJ, Vermorken JB, Liefling AJ, Pinedo HM, Heimans J J: Paclitaxel-induced neuropathy. Ann Oncol 6:489-494, 1995.
-
(1995)
Ann Oncol
, vol.6
, pp. 489-494
-
-
Postma, T.J.1
Vermorken, J.B.2
Liefling, A.J.3
Pinedo, H.M.4
Heimans, J.J.5
-
21
-
-
0027360291
-
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose- limiting
-
Rowinsky EK, Chandhry V, Forastiere AA, Sartorius SE, Ettinger DS, Grochow LB, Lubejko BG, Cornblath DR, Donehower RC: Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. J Clin Oncol 11:2010-2020, 1993. (Pubitemid 23304628)
-
(1993)
Journal of Clinical Oncology
, vol.11
, Issue.10
, pp. 2010-2020
-
-
Rowinsky, E.K.1
Chaudhry, V.2
Forastiere, A.A.3
Sartorius, S.E.4
Ettinger, D.S.5
Grochow, L.B.6
Lubejko, B.G.7
Cornblath, D.R.8
Donehower, R.C.9
-
22
-
-
0024556011
-
Taxol produces a predominantly sensory neuropathy
-
Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, Einzig AI, Wiernik P, Schaumburg HH: Taxol produces a predominantly sensory neuropathy. Neurology 39:368-373, 1989. (Pubitemid 19094727)
-
(1989)
Neurology
, vol.39
, Issue.3
, pp. 368-373
-
-
Lipton, R.B.1
Apfel, S.C.2
Dutcher, J.P.3
Rosenberg, R.4
Kaplan, J.5
Berger, A.6
Einzig, A.I.7
Wiernik, P.8
Schaumburg, H.H.9
-
23
-
-
0028270476
-
Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies
-
Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR: Peripheral neuropathy from taxol and cisplafin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35:304-311, 1994. (Pubitemid 24089653)
-
(1994)
Annals of Neurology
, vol.35
, Issue.3
, pp. 304-311
-
-
Chaudhry, V.1
Rowinsky, E.K.2
Sartorius, S.E.3
Donehower, R.C.4
Cornblath, D.R.5
-
24
-
-
0023595221
-
Phase I trial of taxol given as a 24-hour infusion every 21 days: Responses observed in metastatic melanoma
-
Wiernik PH, Schwartz EL, Einzig A, Strauman J J, Lipton RB, Dutcher JP: Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol 5:1232-1239, 1987. (Pubitemid 18045309)
-
(1987)
Journal of Clinical Oncology
, vol.5
, Issue.8
, pp. 1232-1239
-
-
Wiernik, P.H.1
Schwartz, E.L.2
Einzig, A.3
Strauman, J.J.4
Lipton, R.B.5
Dutcher, J.P.6
-
25
-
-
0028943926
-
Neurotoxicity of cisplatin and taxol
-
Warner E: Neurotoxicity of cisplatin and taxol. Int J Gynecol Cancer 5:161-169, 1995.
-
(1995)
Int J Gynecol Cancer
, vol.5
, pp. 161-169
-
-
Warner, E.1
-
26
-
-
0024327106
-
Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
-
McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC: Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111:273-279, 1989. (Pubitemid 19204753)
-
(1989)
Annals of Internal Medicine
, vol.111
, Issue.4
, pp. 273-279
-
-
McGuire, W.P.1
Rowinsky, E.K.2
Rosenhein, N.B.3
Grumbine, F.C.4
Ettinger, D.S.5
Armstrong, D.K.6
Donehower, R.C.7
-
27
-
-
0038206660
-
Managing taxane toxicities
-
Markman M: Managing taxane toxicities. Support Care Cancer 11:144-147, 2003. (Pubitemid 36733807)
-
(2003)
Supportive Care in Cancer
, vol.11
, Issue.3
, pp. 144-147
-
-
Markman, M.1
-
28
-
-
0025799973
-
Cardiac disturbances during the administration of taxol
-
Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC: Cardiac disturbances during the administration of taxol. J Clin Oncol 9:1704-1712, 1991.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1704-1712
-
-
Rowinsky, E.K.1
McGuire, W.P.2
Guarnieri, T.3
Fisherman, J.S.4
Christian, M.C.5
Donehower, R.C.6
-
29
-
-
0025809298
-
A phase i trial of taxol given by a 6-hour intravenous infusion
-
Brown T, Havlin K, Weiss G, Cagnola J, Koeller J, Kuhn J, Rizzo J, Craig J, Phillips J, Von Hoff D: A phase I trial of taxol given by a 6-hour intravenous infusion. J Cliff Oncol 9:1261-1267, 1991.
-
(1991)
J Cliff Oncol
, vol.9
, pp. 1261-1267
-
-
Brown, T.1
Havlin, K.2
Weiss, G.3
Cagnola, J.4
Koeller, J.5
Kuhn, J.6
Rizzo, J.7
Craig, J.8
Phillips, J.9
Von Hoff, D.10
-
30
-
-
0029948062
-
Transient encephalopathy after paclitaxel (Taxol) infusion
-
Perry JR, Warner E: Transient encephalopathy after paclitaxel (Taxol) infusion. Neurology 46:1596-1599, 1996. (Pubitemid 26185778)
-
(1996)
Neurology
, vol.46
, Issue.6
, pp. 1596-1599
-
-
Perry, J.R.1
Warner, E.2
-
31
-
-
0026354712
-
Phase i trial of taxol, an active drug in the treatment of metastatic breast cancer
-
Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN: Phase I trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797-1805, 1991.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 1797-1805
-
-
Holmes, F.A.1
Walters, R.S.2
Theriault, R.L.3
Forman, A.D.4
Newton, L.K.5
Raber, M.N.6
Buzdar, A.U.7
Frye, D.K.8
Hortobagyi, G.N.9
-
32
-
-
0031801368
-
Phase I study of paclitaxel in patients with recurrent malignant glioma: A North American brain tumor consortium report
-
Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC, Jr., Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD: Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol 16:2188-2194, 1998. (Pubitemid 28265057)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.6
, pp. 2188-2194
-
-
Chang, S.M.1
Kuhn, J.G.2
Rizzo, J.3
Robins, H.I.4
Schold Jr., S.C.5
Spence, A.M.6
Berger, M.S.7
Mehta, M.P.8
Bozik, M.E.9
Pollack, I.10
Gilbert, M.11
Fulton, D.12
Rankin, C.13
Malec, M.14
Prados, M.D.15
-
33
-
-
0034619997
-
Paclitaxel does not cause central nervous adverse effects: A prospective vigilance-controlled EEG mapping study in ovarian cancer patients
-
Mayerhofer K, Bodner K, Saletu B, Bodner-Adler B, Anderer P, Hefler L, Kaider A, Leodolter S, Kainz C: Paclitaxel does not cause central nervous adverse effects: a prospective vigilance-controlled EEG mapping study in ovarian cancer patients. Wien Klin Wochenschr 112:1007-1013, 2000. (Pubitemid 32014571)
-
(2000)
Wiener Klinische Wochenschrift
, vol.112
, Issue.23
, pp. 1007-1013
-
-
Mayerhofer, K.1
Bodner, K.2
Saletu, B.3
Bodner-Adler, B.4
Anderer, P.5
Hefler, L.6
Kaider, A.7
Leodolter, S.8
Kainz, C.9
-
34
-
-
0029889373
-
Peripheral neuropathy secondary to docetaxel (Taxotere)
-
New PZ, Jackson CE, Rinaldi D, Burris H, Barohn RJ: Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology 46:108-111, 1996. (Pubitemid 26156112)
-
(1996)
Neurology
, vol.46
, Issue.1
, pp. 108-111
-
-
New, P.Z.1
Jackson, C.E.2
Rinaldi, D.3
Burris, H.4
Barohn, R.J.5
-
35
-
-
0029888797
-
Peripheral neurotoxicity induced by docetaxel
-
Hilkens PH, Verweij J, Stoter G, Vecht C J, van Putten WL, van den Bent MJ: Peripheral neurotoxicity induced by docetaxel. Neurology 46:104-108, 1996. (Pubitemid 26156111)
-
(1996)
Neurology
, vol.46
, Issue.1
, pp. 104-108
-
-
Hilkens, P.H.E.1
Verweij, J.2
Stoter, G.3
Vecht, Ch.J.4
Van Putten, W.L.J.5
Van Den Bent, M.J.6
-
36
-
-
0031887428
-
Lhermitte's sign following chemotherapy with docetaxel
-
van den Bent MJ, Hilkens PH, Sillevis Smitt PA, van Raaij-van den Aarssen VJ, Bontenbal M, Verweij J: Lhermitte's sign following chemotherapy with docetaxel. Neurology 50:563-564, 1998. (Pubitemid 28119819)
-
(1998)
Neurology
, vol.50
, Issue.2
, pp. 563-564
-
-
Van Den Bent, M.J.1
Hilkens, P.H.E.2
Sillevis Smitt, P.A.E.3
Van Raaij-van Den Aarssen, V.J.M.4
Bontenbal, M.5
Verweij, J.6
-
37
-
-
0034061842
-
Docetaxel administered on a weekly basis for metastatic breast cancer
-
Burstein HJ, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Wirier EP: Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol 18:1212-1219, 2000. (Pubitemid 30159838)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.6
, pp. 1212-1219
-
-
Burstein, H.J.1
Manola, J.2
Younger, J.3
Parker, L.M.4
Bunnell, C.A.5
Scheib, R.6
Matulonis, U.A.7
Garber, J.E.8
Clarke, K.D.9
Shulman, L.N.10
Winer, E.P.11
-
38
-
-
0035184370
-
Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer
-
DOI 10.1023/A:1012557528952
-
Stemmler H J, Gutschow K, Sommer H, Malekmohammadi M, Kentenich CH, Forstpointner R, Geuenich S, Bischoff J, Hiddemann W, Heinemann V: Weekly docetaxel (Taxotere) in patients with metastatic breast cancer. Ann Oncol 12:1393-1398, 2001. (Pubitemid 33100243)
-
(2001)
Annals of Oncology
, vol.12
, Issue.10
, pp. 1393-1398
-
-
Stemmler, H.J.1
Gutschow, K.2
Sommer, H.3
Malekmohammadi, M.4
Kentenich, Ch.5
Forstpointner, R.6
Geuenich, S.7
Bischoff, J.8
Hiddemann, W.9
Heinemann, V.10
-
39
-
-
0036302586
-
Phase II study of weekly docetaxel in patients with metastatic breast cancer
-
DOI 10.1093/annonc/mdf027
-
Aihara T, Kim Y, Takatsuka Y: Phase I study of weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 13:286-292, 2002. (Pubitemid 34704982)
-
(2002)
Annals of Oncology
, vol.13
, Issue.2
, pp. 286-292
-
-
Aihara, T.1
Kim, Y.2
Takatsuka, Y.3
-
40
-
-
2142856685
-
Protracted administration of weekly docetaxel in metastatic breast cancer
-
Kuroi K, Bando H, Saji S, Toi M: Protracted administration of weekly docetaxel in metastatic breast cancer. Oneol Rep 10:1479-1484, 2003.
-
(2003)
Oneol Rep
, vol.10
, pp. 1479-1484
-
-
Kuroi, K.1
Bando, H.2
Saji, S.3
Toi, M.4
-
41
-
-
0031752909
-
Docetaxel and cisplatin in metastatic urothelial cancer: A phase II study
-
Sengelov L, Kamby C, Lund B, Engelholm SA: Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study. J Clin Oncol 16:3392-3397, 1998. (Pubitemid 28481638)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.10
, pp. 3392-3397
-
-
Sengelov, L.1
Kamby, C.2
Lund, B.3
Engelholm, S.A.4
-
42
-
-
0031058721
-
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)
-
DOI 10.1023/A:1008245400251
-
Hilkens PH, Verweij J, Vecht CJ, Stoter G, van den Bent MJ: Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere). Ann Oncol 8:187-190, 1997. (Pubitemid 27112888)
-
(1997)
Annals of Oncology
, vol.8
, Issue.2
, pp. 187-190
-
-
Hilkens, P.H.E.1
Verweij, J.2
Vecht, Ch.J.3
Stoter, G.4
Van Den Bent, M.J.5
-
43
-
-
0036360434
-
Quality of life assessment
-
Shimozuma K: Quality of life assessment. Breast Cancer 9:100-106, 2002.
-
(2002)
Breast Cancer
, vol.9
, pp. 100-106
-
-
Shimozuma, K.1
-
44
-
-
0036369954
-
Hisashige for the task force of the japanese breast cancer society for 'the development of guidelines for quality of life assessment studies of breast cancer patients a: Systematic overview of quality of life studies for breast cancer
-
Shimozuma K, Okamoto T, Katsumata N, Koike M, Tanaka K, Osumi S, Saito M, Shikama N, Watanabe T, Mitsumori M, Yamauchi C, Hisashige for The Task Force of The Japanese Breast Cancer Society for 'The Development of Guidelines for Quality of Life Assessment Studies of Breast Cancer Patients A: Systematic Overview of Quality of Life Studies for Breast Cancer. Breast Cancer 9:196-202, 2002.
-
(2002)
Breast Cancer
, vol.9
, pp. 196-202
-
-
Shimozuma, K.1
Okamoto, T.2
Katsumata, N.3
Koike, M.4
Tanaka, K.5
Osumi, S.6
Saito, M.7
Shikama, N.8
Watanabe, T.9
Mitsumori, M.10
Yamauchi, C.11
-
45
-
-
84858118341
-
Breast cancer treatment and quality of life of patients
-
Ohsumi S, Shimozuma K: Breast cancer treatment and quality of life of patients. Jpn J Breast Cancer 18:113-120, 2003.
-
(2003)
Jpn J Breast Cancer
, vol.18
, pp. 113-120
-
-
Ohsumi, S.1
Shimozuma, K.2
-
46
-
-
0030804578
-
Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy
-
DOI 10.1016/S0959-8049(97)00103-2, PII S0959804997001032
-
Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, Pirker R: Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy. EurJ Cancer 33:1393-1399, 1997. (Pubitemid 27404896)
-
(1997)
European Journal of Cancer Part A
, vol.33
, Issue.9
, pp. 1393-1399
-
-
Berger, T.1
Malayeri, R.2
Doppelbauer, A.3
Krajnik, G.4
Huber, H.5
Auff, E.6
Pirker, R.7
-
47
-
-
0030839691
-
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing
-
DOI 10.1023/A:1005805907311
-
Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM: Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing.JNeuroonco135:47-53, 1997. (Pubitemid 27361845)
-
(1997)
Journal of Neuro-Oncology
, vol.35
, Issue.1
, pp. 47-53
-
-
Forsyth, P.A.1
Balmaceda, C.2
Peterson, K.3
Seidman, A.D.4
Brasher, P.5
DeAngelis, L.M.6
-
48
-
-
0033544430
-
Total neuropathy score: Validation and reliability study
-
Cornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, Joh T: Total neuropathy score: validation and reliability study. Neurology 53:1660-1664, 1999. (Pubitemid 29530336)
-
(1999)
Neurology
, vol.53
, Issue.8
, pp. 1660-1664
-
-
Cornblath, D.R.1
Chaudhry, V.2
Carter, K.3
Lee, D.4
Seysedadr, M.5
Miernicki, M.6
Joh, T.7
-
49
-
-
0032805275
-
Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy
-
DOI 10.1007/s005200050275
-
du Bois A, Schlaich M, Luck HJ, Mollenkopf A, Wechsel U, Rauchholz M, Bauknecht T, Meerpohl HG: Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care Cancer 7:354-361, 1999. (Pubitemid 29399982)
-
(1999)
Supportive Care in Cancer
, vol.7
, Issue.5
, pp. 354-361
-
-
Du Bois, A.1
Schlaich, M.2
Luck, H.-J.3
Mollenkopf, A.4
Wechsel, U.5
Rauchholz, M.6
Bauknecht, T.7
Meerpohl, H.-G.8
-
50
-
-
0036727187
-
Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer
-
DOI 10.1200/JCO.2002.08.057
-
Modi S, Panageas KS, Duck ET, Bach A, Weinstock N, Dougherty J, Cramer L, Hudis C, Norton L, Seidman A: Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. J Clin Onco120:3665-3673, 2002. (Pubitemid 34983227)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.17
, pp. 3665-3673
-
-
Modi, S.1
Panageas, K.S.2
Duck, E.T.3
Bach, A.4
Weinstock, N.5
Dougherty, J.6
Cramer, L.7
Hudis, C.8
Norton, L.9
Seidman, A.10
-
51
-
-
0032809977
-
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer
-
Bishop JF, Dewar J, Toner GC, Smith J, Tattersall MH, Olver IN, Ackland S, Kennedy I, Goldstein D, Gurney H, Walpole E, Levi J, Stephenson J, Canetta R: Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol 17:2355-2364, 1999. (Pubitemid 29368233)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.8
, pp. 2355-2364
-
-
Bishop, J.F.1
Dewar, J.2
Toner, G.C.3
Smith, J.4
Tattersall, M.H.N.5
Olver, I.N.6
Ackland, S.7
Kennedy, I.8
Goldstein, D.9
Gurney, H.10
Walpole, E.11
Levi, J.12
Stephenson, J.13
Canetta, R.14
-
52
-
-
0033860004
-
Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: Quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist
-
DOI 10.1016/S0959-8049(00)00134-9, PII S0959804900001349
-
Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, Bontenbal M, van Pottelsberghe C, Groenvold M, Paridaens R: Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. EurJ Cancer 36:1488-1497, 2000. (Pubitemid 30619001)
-
(2000)
European Journal of Cancer
, vol.36
, Issue.12
, pp. 1488-1497
-
-
Kramer, J.A.1
Curran, D.2
Piccart, M.3
De Haes, J.C.J.M.4
Bruning, P.F.5
Klijn, J.G.M.6
Bontenbal, M.7
Van Pottelsberghe, C.8
Groenvold, M.9
Paridaens, R.10
|